Skip to main content

Advertisement

SpringerLink
Log in

Low-grade gliomas: The debate continues

  • Published:
Current Oncology Reports Aims and scope Submit manuscript

Abstract

Low-grade gliomas (LGG) are a heterogeneous group of tumors that tend to occur primarily in young adults and children. They are indolent, progressive, and often undergo anaplastic transformation. The prognosis of these tumors is primarily affected by age and pathologic type. Many questions remain in the management of LGGs, including the role of surgical resection (ie, maximal tumor resection), the optimal timing of radiation (ie, postoperative vs at the time of tumor progression), and the role of chemotherapy (ie, salvage after radiotherapy, primary treatment after surgery, concurrent with radiotherapy). Further complicating treatment decisions are concerns about toxicity with any intervention because LGG patients can often lead a relatively normal existence for years with no intervention. In this article we review the pertinent LGG literature published over the past few years and its impact on the management of LGGs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Kleihues P, Cavenee WK: Pathology and Genetics of Tumors of the Nervous System: WHO classification of Tumours. Lyon:IARC Press; 2000.

    Google Scholar 

  2. Shaw EG, Scheithauer BW, O’Fallon JR: Supratentorial gliomas: a comparative study by grade and histologic type. J Neurooncol 1997, 31:273–278.

    Article  PubMed  CAS  Google Scholar 

  3. Brown PD, Buckner JC, O’Fallon JR, et al.: Importance of baseline mini-mental state examination as a prognostic factor for patients with low-grade glioma. Int J Radiat Oncol Biol Phys 2004, 59:117–125.

    Article  PubMed  Google Scholar 

  4. Shaw E, Arusell R, Scheithauer B, et al.: Prospective randomized trial of low-versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/ Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study. [see comments]. J Clin Oncol 2002, 20:2267–2276. Prospective phase III radiotherapy dose-finding Intergroup trial.

    Article  PubMed  CAS  Google Scholar 

  5. Okamoto Y, Di Patre PL, Burkhard C, et al.: Populationbased study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas. Acta Neurophathol 2004, 108:49–56.

    Article  Google Scholar 

  6. Cairncross G, Macdonald D, Ludwin S, et al.: Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 1994, 12:2013–2021.

    PubMed  CAS  Google Scholar 

  7. Hoang-Xuan K, Capelle L, Kujas M, et al.: Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions. J Clin Oncol 2004, 22:3133–3138.

    Article  PubMed  CAS  Google Scholar 

  8. Buckner JC, Ballman KV, Scheithauer BW, et al.: Diagnostic and prognostic significance of 1p and 19q deletions in patients (pts) with low-grade oligodendroglioma and astrocytoma [abstract]. Proc ASCO 2005, 24:1502.

    Google Scholar 

  9. Esteller M, Garcia-Foncillas J, Andion E, et al.: Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents.[see comment][erratum appears in N Engl J Med 2000 Dec 7;343(23):1740]. N Engl J Med 2000, 343:1350–1354.

    Article  PubMed  CAS  Google Scholar 

  10. Komine C, Watanabe T, Katayama Y, et al.: Promoter hypermethylation of the DNA repair gene O6-methylguanine-DNA methyltransferase is an independent predictor of shortened progression free survival in patients with low-grade diffuse astrocytomas. Brain Pathol 2003, 13:176–184.

    Article  PubMed  CAS  Google Scholar 

  11. Connor SE, Gunny R, Hampton T, et al.: Magnetic resonance image registration and subtraction in the assessment of minor changes in low grade glioma volume. Eur Radiol 2004, 14:2061–2066.

    Article  PubMed  CAS  Google Scholar 

  12. Jenkinson MD, Smith T, Joyce K, et al.: MRS of oligodendroglial tumors. Neurology 2005, 64:2085–2089.

    Article  PubMed  CAS  Google Scholar 

  13. Hakyemez B, Erdogan C, Ercan I, et al.: High-grade and low-grade gliomas: differentiation by using perfusion MR imaging. Clin Radiol 2005, 60:493–502.

    Article  PubMed  CAS  Google Scholar 

  14. Giammarile F, Cinotti LE, Jouvet A, et al.: High and low grade oligodendrogliomas (ODG): correlation of aminoacid and glucose uptakes using PET and histological classifications. J Neurooncol 2004, 68:263–274.

    Article  PubMed  CAS  Google Scholar 

  15. Surma-aho O, Niemela M, Vilkki J, et al.: Adverse longterm effects of brain radiotherapy in adult low-grade glioma patients. Neurology 2001, 56:1285–1290.

    PubMed  CAS  Google Scholar 

  16. Shaw EG, Won M, Brachman D, et al.: Preliminary results of RTOG Protocol 9802: A phase II study of observation in completely resected adult low-grade glioma. Presented at World Federation of Neuro-Oncology. Edinburgh, Scotland; 2005. A prospective Intergroup observational study for "low risk" lowgrade gliomas.

  17. van den Bent M, Afra D, De Witte O, et al.: Long-term efficacy of early versus delayed radiotherapy for lowgrade astrocytoma and oligodendrogliglioma in adults: the EORTC 22845 randomised trial. Lancet, 2005, 366:985–990. Long-term results of a phase III study testing early versus delayed radiotherapy for low-grade glioma patients.

    Article  PubMed  Google Scholar 

  18. Kondziolka D, Lunsford LID, Martinez AJ: Unreliability of contemporary neurodiagnostic imaging in evaluating suspected adult supratentorial (low-grade) astrocytoma. J Neurosurg 1993, 79:533–536.

    PubMed  CAS  Google Scholar 

  19. Recht LD, Lew R, Smith TW: Suspected low-grade glioma: is deferring treatment safe? [see comments]. Ann Neurol 1992, 31:431–436.

    Article  PubMed  CAS  Google Scholar 

  20. Reijneveld JC, Sitskoorn MM, Klein M, et al.: Cognitive status and quality of life in patients with suspected versus proven low-grade gliomas. Neurology 2001, 56:618–623.

    PubMed  CAS  Google Scholar 

  21. Karim AB, Maat B, Hatlevoll R, et al.: A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844. Int J Radiat Oncol Biol Phys 1996, 36:549–556. Prospective phase III radiotherapy dose finding trial.

    Article  PubMed  CAS  Google Scholar 

  22. Florell RC, Macdonald DR, Irish WD, et al.: Selection bias, survival, and brachytherapy for glioma.[erratum appears in J Neurosurg 1992 Sep;77(3):489]. J Neurosurg 1992, 76:179–183.

    PubMed  CAS  Google Scholar 

  23. Duffau H, Lopes M, Arthuis F, et al.: Contribution of intraoperative electrical stimulations in surgery of low grade gliomas: a comparative study between two series without (1985-96) and with (1996-2003) functional mapping in the same institution. J Neurol Neurosurg Psychiatry 2005, 76:845–851.

    Article  PubMed  CAS  Google Scholar 

  24. Claus EB, Horlacher A, Hsu L, et al.: Survival rates in patients with low-grade glioma after intraoperative magnetic resonance image guidance. Cancer 2005, 103:1227–1233.

    Article  PubMed  Google Scholar 

  25. Karim AB, Afra D, Cornu P, et al.: Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. Int J Radiat Oncol Biol Phys 2002, 52:316–324.

    Article  PubMed  Google Scholar 

  26. Kortmann RD, Jeremic B, Weller M, et al.: Immediate postoperative radiotherapy or "watch and wait" in the management of adult low-grade glioma? Strahlentherapie und Onkologie 2004, 180:408–418.

    PubMed  Google Scholar 

  27. Sofietti R, Borgognone M, Ducati A, et al.: Efficacy of radiation therapy on seizures in low-grade astrocytomas[abstract 422]. Presented at World Federation of Neuro-Oncology. Edinburgh; 2005:111.

  28. Reichenthal E, Feldman Z, Cohen ML: Hemispheric supratentorial low-grade astrocytomas. Neurochirurgia 1992, 35:18–22.

    PubMed  CAS  Google Scholar 

  29. Kelly PJ, Daumas-Duport C, Scheithauer BW: Stereotactic histologic correlations of computed tomography and magnetic resonance imaging-defined abnormalities in patients with glial neoplasms. Mayo Clin Proc 1987, 62:450–459. A landmark study illustrating the infiltrative nature of gliomas.

    PubMed  CAS  Google Scholar 

  30. Marcus KJ, Goumnerova L, Billett AL, et al.: Stereotactic radiotherapy for localized low-grade gliomas in children: final results of a prospective trial. Int J Radiat Oncol Biol Physics 2005, 61:374–379.

    Article  Google Scholar 

  31. Sheline GE, Wara WM, Smith V: Therapeutic irradiation in brain injury. Int J Radiat Oncol Biol Physics 1980, 6:1215–1228.

    CAS  Google Scholar 

  32. Brown PD, Buckner JC, Uhm JH, et al.: The neurocognitive effects of radiation in adult low-grade glioma patients. Neuro-Oncology 2003, 5:161–167.

    Article  PubMed  Google Scholar 

  33. Klein M, Heimans JJ, Aaronson NK, et al.: Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study. Lancet 2002, 360:1361–1368. A retrospective investigation of cognitive status of low-grade glioma patients and the significant impact of the tumor itself in these patients.

    Article  PubMed  CAS  Google Scholar 

  34. Swennen MH, Bromberg JE, Witkamp TD, et al.: Delayed radiation toxicity after focal or whole brain radiotherapy for low-grade glioma. J Neurooncol 2004, 66:333–339.

    Article  PubMed  CAS  Google Scholar 

  35. Kleinberg L, Wallner K, Malkin MG: Good performance status of long-term disease-free survivors of intracranial gliomas [published erratum appears in Int J Radiat Oncol Biol Phys 1993 Jun 15;26(3):563] [see comments]. Int J Radiat Oncol Biol Physics 2 1993, 6:129–133.

    Google Scholar 

  36. Gregor A, Cull A, Traynor E, et al.: Neuropsychometric evaluation of long-term survivors of adult brain tumours: relationship with tumour and treatment parameters. Radiother Oncol 1996, 41:55–59.

    PubMed  CAS  Google Scholar 

  37. Curnes JT, Laster DW, Ball MR, et al.: MRI of radiation injury to the brain. AJR Am J Roentgenol 1986, 147:119–124.

    PubMed  CAS  Google Scholar 

  38. Scheibel RS, Meyers CA, Levin VA: Cognitive dysfunction following surgery for intracerebral glioma: influence of histopathology, lesion location, and treatment. J Neurooncol 1996, 30:61–69.

    Article  PubMed  CAS  Google Scholar 

  39. Imperato JP, Paleologos NA, Vick NA: Effects of treatment on long-term survivors with malignant astrocytomas [see comment]. Ann Neurol 1990, 28:818–822.

    Article  PubMed  CAS  Google Scholar 

  40. Laack NN, Brown PD: Cognitive sequelae of brain radiation in adults. Semin Oncol 2004, 31:702–713.

    Article  PubMed  Google Scholar 

  41. Laack N, Brown P, Furth A, et al.: Neurocognitive function after radiotherapy (RT) for supratentorial low-grade gliomas (LGG): results of a North Central Cancer Treatment Group (NCCTG) prospective study [abstract 18]. Int J Radiat Oncol Biol Phys 2003, 57:134.

    Google Scholar 

  42. Armstrong CL, Hunter JV, Ledakis GE, et al.: Late cognitive and radiographic changes related to radiotherapy: initial prospective findings [see comments]. Neurology 2002, 59:40–48.

    PubMed  CAS  Google Scholar 

  43. Vigliani MC, Sichez N, Poisson M, et al.: A prospective study of cognitive functions following conventional radiotherapy for supratentorial gliomas in young adults: 4-year results. Int J Radiat Oncol Biol Phys 1996, 35:527–533.

    Article  PubMed  CAS  Google Scholar 

  44. Torres IJ, Mundt AJ, Sweeney PJ, et al.: A longitudinal neuropsychological study of partial brain radiation in adults with brain tumors. Neurology 2003, 60:1113–1118.

    Article  PubMed  CAS  Google Scholar 

  45. Hirsch J-F, Sainte Rose C, Pierre-Kahn A: Benign astrocytic and oligodendrocytic tumors of the cerebral hemispheres in children. J Neurosurg 1989, 70:568–572.

    Article  PubMed  CAS  Google Scholar 

  46. Eyre HJ, Crowley JJ, Townsend JJ, et al.: A randomized trial of radiotherapy versus radiotherapy plus CCNU for incompletely resected low-grade gliomas: a Southwest Oncology Group study. J Neurosurg 1993, 78:909–914.

    PubMed  CAS  Google Scholar 

  47. Buckner JC, Gesme D, O’Fallon JR, et al.: Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma: efficacy and associations with chromosomal abnormalities. J Clin Oncol 2003, 21:251–255.

    Article  PubMed  CAS  Google Scholar 

  48. Pace A, Vidiri A, Galie E, et al.: Temozolomide chemotherapy for progressive low-grade glioma: clinical benefits and radiological response [see comment]. Ann Oncol 2003, 14:1722–1726.

    Article  PubMed  CAS  Google Scholar 

  49. Quinn JA, Reardon DA, Friedman AH, et al.: Phase II trial of temozolomide in patients with progressive low-grade glioma [see comment]. J Clin Oncol 2003, 21:646–651.

    Article  PubMed  CAS  Google Scholar 

  50. Brada M, Viviers L, Abson C, et al.: Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas [see comment]. Ann Oncol 2003, 14:1715–1721.

    Article  PubMed  CAS  Google Scholar 

  51. Brown P, Buckner J: Temozolomide: too early for definitive conclusions. J Clin Oncol 2003, 21:3710.

    Article  PubMed  Google Scholar 

  52. Stupp R, Mason WP, van den Bent M, et al.: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005, 352:987–996.

    Article  PubMed  CAS  Google Scholar 

  53. Pignatti F, van den Bent M, Curran D, et al.: Prognostic factors for survival in adult patients with cerebral low-grade glioma. J Clin Oncol 2002, 20:2076–2084. A prognostic scoring system derived and validated from prospective databases.

    Article  PubMed  Google Scholar 

  54. Buckner JC, Burch PA, Schaefer PL, et al.: Phase II trial of nitrogen mustard, vincristine, and procarbazine (MOP) in patients with recurrent glioma: NCCTG results [abstract]. Proc ASCO 1996, 25:283.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Oncology, Mayo Clinic Rochester, 200 SW 1st Street, 55905, Rochester, MN, USA

    Paul D. Brown MD

Authors
  1. Paul D. Brown MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brown, P.D. Low-grade gliomas: The debate continues. Curr Oncol Rep 8, 71–77 (2006). https://doi.org/10.1007/s11912-006-0012-x

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11912-006-0012-x

Keywords

Search

Navigation